Ozanimod
Records for this ingredient, by country (identity only).
ATC L04AE02 · 9 markets · 23 records
AU 5 records · 5 shown of 5
- 0.92 mgcapsuleZEPOSIA
- 0.23 mgcapsuleZEPOSIA
- 1 mgcapsuleZEPOSIA ozanimod 920 microgram capsules blister pack
- 0.5 mgcapsuleZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack
- 0.25 mgcapsuleZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
GB 4 records · 0 shown of 0
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 3 records · 3 shown of 3
JP 3 records · 2 shown of 2
- 0.92 mgcapsuleゼポジアカプセル0.92mg
- 1 %/1 mLotherシアナマイド内用液1%「タナベ」
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
HK 2 records · 0 shown of 0
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
US 1 records · 1 shown of 1
- 0.92 mgcapsuleZEPOSIA
EU 1 records · 0 shown of 0
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | ES | TW | HK | JP | EU |
|---|---|---|---|---|---|---|---|---|---|
| 0.92 mgRecorded as: 920 microgram capsule | ZEPOSIA | ZEPOSIA | ZEPOSIA | ZEPOSIA | ZEPOSIA 捷保舒膠囊0.92毫克 | ゼポジアカプセル0.92mg | |||
| 0.23 mgRecorded as: 230 microgram capsule | ZEPOSIA | ZEPOSIA | ZEPOSIA | ZEPOSIA 捷保舒膠囊0.23毫克 | |||||
| 0.46 mg capsule | ZEPOSIA | ZEPOSIA 捷保舒膠囊0.46毫克 | |||||||
| 1 mg capsule | ZEPOSIA ozanimod 920 microgram capsules blister pack | ||||||||
| 0.5 mgRecorded as: 500 microgram capsule | ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack | ||||||||
| 0.25 mgRecorded as: 250 microgram capsule | ZEPOSIA ozanimod 230 microgram and 460 microgram capsules blister wallet composite pack | ||||||||
| 1 %/1 mL other | シアナマイド内用液1%「タナベ」 | ||||||||
unknown | ZEPOSIA | ZEPOSIA ZEPOSIA CAPSULES 0.23MG AND 0.46MG (TREATMENT INITIATION PACK) | ZEPOSIA | ||||||
capsule | ZEPOSIA Zeposia 0.23mg/0.46mg capsules treatment initiation pack | ゼポジアカプセルスターターパック |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in GB · JP and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en GB · JP que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 GB · JP 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 GB · JP 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.